132 related articles for article (PubMed ID: 24942027)
41. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group.
Schnater JM; Aronson DC; Plaschkes J; Perilongo G; Brown J; Otte JB; Brugieres L; Czauderna P; MacKinlay G; Vos A
Cancer; 2002 Feb; 94(4):1111-20. PubMed ID: 11920482
[TBL] [Abstract][Full Text] [Related]
42. Hepatoblastoma--report of three cases.
Samantaray S; Rout N; Mishra DP; Mallik RN
Indian J Pathol Microbiol; 2003 Oct; 46(4):643-5. PubMed ID: 15025365
[TBL] [Abstract][Full Text] [Related]
43. Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
Hsiao CC; Kao YH; Huang SC; Chuang JH
Pediatr Blood Cancer; 2013 Feb; 60(2):248-53. PubMed ID: 22648929
[TBL] [Abstract][Full Text] [Related]
44. Two Cases of Hepatoblastoma in Young Adults.
de Bree K; Westermann AM; Klümpen HJ; Verheij J; Phoa SSKS; Oomen M; van Gulik TM
J Adolesc Young Adult Oncol; 2018 Jun; 7(3):404-408. PubMed ID: 29412770
[TBL] [Abstract][Full Text] [Related]
45. Clinicomorphological observation of refractory hepatoblastoma: a case report.
Filenko BM; Starchenko II; Royko NV; Vynnyk NI; Dyachenko LV
Exp Oncol; 2020 Sep; 42(3):245-247. PubMed ID: 32996745
[TBL] [Abstract][Full Text] [Related]
46. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
[TBL] [Abstract][Full Text] [Related]
47. Hepatoblastoma in a child of extremely low birth weight.
Jaing TH; Hung IJ; Lin JN; Lien RI; Hsueh C; Lu CS
Am J Perinatol; 2002 Apr; 19(3):149-53. PubMed ID: 12012290
[TBL] [Abstract][Full Text] [Related]
48. Complementary roles of β-catenin and glutamine synthetase immunostaining in diagnosis of chemotherapy-treated and untreated hepatoblastoma.
Huang WJ; Tsai JH; Jeng YM
J Formos Med Assoc; 2017 Jul; 116(7):549-553. PubMed ID: 28277286
[TBL] [Abstract][Full Text] [Related]
49. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue.
Kobrinsky NL; Sjolander DE; Goldenberg JA; Ortmeier TC
Pediatr Blood Cancer; 2005 Aug; 45(2):222-5. PubMed ID: 15770640
[TBL] [Abstract][Full Text] [Related]
50. AFP negative cystic liver lesion in a child should let one think of hepatoblastoma.
Goedeke J; Haeberle B; Schmid I; von Schweinitz D
J Pediatr Hematol Oncol; 2011 Aug; 33(6):e245-7. PubMed ID: 21383638
[TBL] [Abstract][Full Text] [Related]
51. Treatment of infantile hepatoblastoma and related complications.
Ueno S; Hirakawa H; Yokoyama S; Hinoki T; Tobita K; Ohtani Y; Imaizumi T; Makuuchi H; Iwata Y; Imai Y
Tokai J Exp Clin Med; 2005 Dec; 30(4):203-9. PubMed ID: 16482940
[TBL] [Abstract][Full Text] [Related]
52. Outcomes for patients with congenital hepatoblastoma.
Trobaugh-Lotrario AD; Chaiyachati BH; Meyers RL; Häberle B; Tomlinson GE; Katzenstein HM; Malogolowkin MH; von Schweinitz D; Krailo M; Feusner JH
Pediatr Blood Cancer; 2013 Nov; 60(11):1817-25. PubMed ID: 23798361
[TBL] [Abstract][Full Text] [Related]
53. Geotrichum candidum septicemia in a child with hepatoblastoma.
André N; Coze C; Gentet JC; Perez R; Bernard JL
Pediatr Infect Dis J; 2004 Jan; 23(1):86. PubMed ID: 14743060
[No Abstract] [Full Text] [Related]
54. Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group.
Cacciavillano WD; Brugières L; Childs M; Shafford E; Brock P; Pritchard J; Mailbach R; Scopinaro M; Perilongo G
Eur J Cancer; 2004 Oct; 40(15):2274-9. PubMed ID: 15454253
[TBL] [Abstract][Full Text] [Related]
55. Outcomes of pulmonary metastases in hepatoblastoma--is the prognosis always poor?
Wanaguru D; Shun A; Price N; Karpelowsky J
J Pediatr Surg; 2013 Dec; 48(12):2474-8. PubMed ID: 24314189
[TBL] [Abstract][Full Text] [Related]
56. Pre- and postnatal imaging of a congenital hepatoblastoma.
Al-Hussein HA; Graham EM; Tekes A; Huisman TA
Fetal Diagn Ther; 2011; 30(2):157-9. PubMed ID: 21625071
[TBL] [Abstract][Full Text] [Related]
57. X-Linked Severe Combined Immunodeficiency and Hepatoblastoma: A Case Report and Review of Literature.
Diaz-Parra S; Lozano-Sanchez G; Escobosa-Sanchez O; Moreno-Perez D; Morales-Martinez A; Armengol-Niell C; Acha-Garcia T
J Pediatr Hematol Oncol; 2018 Aug; 40(6):e348-e349. PubMed ID: 29620683
[TBL] [Abstract][Full Text] [Related]
58. The association of hepatoblastoma, prematurity and cerebral palsy: Case reports.
Pruente JR; Deike DE; Lockart B; Gaebler-Spira D
J Pediatr Rehabil Med; 2020; 13(2):185-188. PubMed ID: 32444576
[TBL] [Abstract][Full Text] [Related]
59. Antenatal diagnosis of congenital hepatoblastoma in utero.
Shih JC; Tsao PN; Huang SF; Yen BL; Lin JH; Lee CN; Hsieh FJ
Ultrasound Obstet Gynecol; 2000 Jul; 16(1):94-7. PubMed ID: 11084976
[TBL] [Abstract][Full Text] [Related]
60. [Neonatal hepatoblastoma--a case report].
Chen ZH; Lu GJ; Han YK; Li WD; Wu ZJ
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):631-2. PubMed ID: 16191285
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
